These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12727584)

  • 41. Disproportionately elevated proinsulinemia is observed at modestly elevated glucose levels within the normoglycemic range.
    Lorenzo C; Hanley AJ; Rewers MJ; Haffner SM
    Acta Diabetol; 2014 Aug; 51(4):617-23. PubMed ID: 24532116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation.
    Rudovich NN; Weickert MO; Pivovarova O; Bernigau W; Pfeiffer AF
    Diabetes Technol Ther; 2011 Jun; 13(6):615-23. PubMed ID: 21488802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of different volumes of high-intensity interval training on proinsulin in participants with the metabolic syndrome: a randomised trial.
    Ramos JS; Dalleck LC; Borrani F; Mallard AR; Clark B; Keating SE; Fassett RG; Coombes JS
    Diabetologia; 2016 Nov; 59(11):2308-2320. PubMed ID: 27480182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
    Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
    J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals.
    Eriksson JG; Forsén T; Tuomilehto J; Jaddoe VW; Osmond C; Barker DJ
    Diabetologia; 2002 Mar; 45(3):342-8. PubMed ID: 11914739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperproinsulinemia in type II diabetes.
    Cohen RM; Nathan DM; Clements RS
    Diabetes Care; 1992 May; 15(5):723-4. PubMed ID: 1516496
    [No Abstract]   [Full Text] [Related]  

  • 47. The many faces of proinsulin.
    Jenssen T
    Scand J Clin Lab Invest; 2006; 66(1):5-6. PubMed ID: 16464781
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of proinsulin analysis for estimates of insulin resistance].
    Stejskal D; Pastorková R; Bartek J; Růzicka V; Horalík D
    Vnitr Lek; 1999 Feb; 45(2):110-4. PubMed ID: 15641230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced Adipose Expression of Interferon Regulatory Factor (IRF)-5 Associates with the Signatures of Metabolic Inflammation in Diabetic Obese Patients.
    Sindhu S; Kochumon S; Thomas R; Bennakhi A; Al-Mulla F; Ahmad R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32188105
    [No Abstract]   [Full Text] [Related]  

  • 50. Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance.
    El Dib R; Gameiro OL; Ogata MS; Módolo NS; Braz LG; Jorge EC; do Nascimento P; Beletate V
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD005525. PubMed ID: 26020622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007).
    Esteghamati A; Ashraf H; Khalilzadeh O; Zandieh A; Nakhjavani M; Rashidi A; Haghazali M; Asgari F
    Nutr Metab (Lond); 2010 Apr; 7():26. PubMed ID: 20374655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A two-year clinical lifestyle intervention program for weight loss in obesity.
    Andersson K; Karlström B; Fredén S; Petersson H; Ohrvall M; Zethelius B
    Food Nutr Res; 2008; 52():. PubMed ID: 19109657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance.
    Delgado-Borrego A; Liu YS; Jordan SH; Agrawal S; Zhang H; Christofi M; Casson D; Cosimi AB; Chung RT
    Liver Transpl; 2008 Feb; 14(2):193-201. PubMed ID: 18236394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
    Pfützner A; Kunt T; Hohberg C; Mondok A; Pahler S; Konrad T; Lübben G; Forst T
    Diabetes Care; 2004 Mar; 27(3):682-7. PubMed ID: 14988285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.
    Vangipurapu J; Stančáková A; Kuulasmaa T; Kuusisto J; Laakso M
    PLoS One; 2015; 10(4):e0124028. PubMed ID: 25853252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others].
    Forst T; Pfützner A
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S268-73. PubMed ID: 17139585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance.
    McLaughlin TL; Reaven GM
    Am J Med; 2003 Apr; 114(6):501-2. PubMed ID: 12727584
    [No Abstract]   [Full Text] [Related]  

  • 58. Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
    Pradhan AD; Manson JE; Meigs JB; Rifai N; Buring JE; Liu S; Ridker PM
    Am J Med; 2003 Apr; 114(6):438-44. PubMed ID: 12727576
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.